Evaluation of the efficacy of indapamide in the treatment of essential arterial hypertension
Papi, L.; Ballestra, A.M.; Tomei, G.; Filice, M.; Giustarini, C.
Bollettino Della Societa Italiana di Cardiologia 26(11): 1585-1588
1981
ISSN/ISBN: 0037-878X PMID: 7349210 Document Number: 176393
Document emailed within 1 workday
Related Documents
Passeron, J.; Pauly, N.; Desprat, J. 1981: International multicentre study of indapamide in the treatment of essential arterial hypertension Postgraduate Medical Journal 57 Suppl. 2: 57-59Chanudet, X.; De Champvallins, M. 2001: Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension International Journal of Clinical Practice 55(4): 233-239
Spannbrucker, N.; Achhammer, I.; Metz, P.; Glocke, M. 1988: Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension Arzneimittel-Forschung 38(1a): 190-193
Andréjak, M.; Zannad, Fïez.; Laville, M.; Duru, Gérard.; Mourad, J-Jacques.; Waeber, B. 2003: Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment Therapie 58(4): 351-352
Bhalla, K.K. 1981: Evaluation of the effect of indapamide on moderate benign essential hypertension complicated by airways obstruction Postgraduate Medical Journal 57(Suppl 2): 34-36
Mariani, A.; Brun, M.; Rongoni, R.; Mariotti, W.; Caporicci, D. 1987: Treatment of essential systemic arterial hypertension with captopril only. Evaluation especially in aged patients La Clinica Terapeutica 121(5): 401-409
Sokolova, L.A.; Bondarenko, B.B.; Evdokimova, T.A. 1992: Comparative evaluation of cardiovascular system reactivity in patients with borderline arterial hypertension and the early stages of essential hypertension Fiziologiia Cheloveka 18(1): 128-135
Tosti-Croce, C.; Mantellini, R.; Fanti, P.; Sciarra, F. 1983: Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension Minerva Medica 74(14-15): 791-797
Runikhina, N.K.; Tkacheva, O.N. 2008: Efficacy of long acting calcium antagonist felodipine in smoking women with essential arterial hypertension Kardiologiia 48(9): 50-52
Zilenovski, A.M.; Freire, C.A.; Iverson, M.T. 1984: Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 42(6): 435-441
Consolo, G.; Pavia, L.; Buttafarro, A.; Casella, F.; Lo Presti, G.; Cogode, R.; Casella, G. 1983: Echocardiographic evaluation of the anatomo-functional changes in essential arterial hypertension Cardiologia 28(6): 527-531
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Paladini, G.; Sgoifo, E. 1980: Dioodobufenine in the treatment of essential arterial hypertension Minerva Cardioangiologica 28(5): 303-308
Ghiuru, R.; Rezuş, C.; Ambăruş, V.; Ionescu, S.; Cosovanu, A. 2001: Nebivolol treatment in essential arterial hypertension Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 105(4): 756-759
Garnier, L.F. 1988: Essential arterial hypertension. from notion to treatment Annales de Cardiologie et d'Angeiologie 37(7): 371-380
Pérez-Grovas, H.; Fernández, M.; Arriaga, J.; Herrera-Acosta, J. 1986: Enalapril in the treatment of essential arterial hypertension Archivos del Instituto de Cardiologia de Mexico 56(5): 379-390
Melina, D.; Guerrera, G.; Martino, G.; Salera, P.; Gattini, G.; Savi, L.; Cardillo, G. 1985: Evaluation of plasma renin activity as a cardiovascular risk factor in essential arterial hypertension Minerva Cardioangiologica 33(11): 717-723
Mroczek, W.J. 1983: Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects PharmacoTherapy 3(2 Part 1): 61-67
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Koaté, P.; Diouf, S.; Sylla, M.; Sarr, M.; Ba, S.A. 1983: The place of guanfacine in the treatment of essential arterial hypertension Dakar Medical 28(2): 321-336